SelectScience Interviews

Advances in Immunotherapy with Potential to Target All Human Cancers

5 May 2016
Advances in Immunotherapy with Potential to Target All Human Cancers

Scientists at the Purdue Center for Drug Discovery discuss the latest innovative research from the lab. Watch the video to find out how technological advances in engineered T-cell therapy can target tumors with enhanced selectivity, sensitivity and control.

About the company

SelectScience logo

SelectScience

Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.

Other videos from SelectScience

Links

Advances in Immunotherapy with Potential to Target All Human Cancers